Apoptosis  by Humke, Eric W
R48
Web alert
Apoptosis
Chemistry & Biology 2000, 7:R48–R49
1074-5521/00/$ – see front matter © 2000
Elsevier Science Ltd. All rights reserved.
Apoptosis, also known as
programmed cell death, is essential
for the normal development and
homeostasis of multicellular
organisms. Apoptosis is the
physiological mechanism by which
the body deliberately eliminates
autoreactive cells and
counterbalances cell division (for
background information see
http://www.ultranet.com/~jkimball/
BiologyPages/A/Apoptosis.html). The
conservation of apoptosis throughout
evolution underscores its
fundamental importance.
Dysregulation of programmed cell
death may contribute to the
pathogenesis of diseases in which
there is insufficient apoptosis, such
as cancer, or excessive apoptosis,
such as Alzheimer’s disease.
Apoptosis was first characterized
microscopically by morphological
cellular changes during tissue
remodeling, and many of the
underlying biochemical components
have been discovered in recent years. 
The Entrez medline literature
search (http://www4.ncbi.nlm.nih.gov/
Entrez/) is a powerful online resource,
but the number of articles on
apoptosis is overwhelming (currently
over 29,000 on medline). There are
many websites specifically devoted
to apoptosis that can distill the
important components of apoptosis
and help to organise all this
information. This month’s Web alert
provides a few starting points.
Hallmarks of apoptosis
Apoptosis is characterized by
morphological changes that take
place within the cell (see the
Apoptosis Dance of Death at
http://lbfa.ujf-grenoble.fr/sites1/www.
cellsalive.com/apop.htm). Unlike
‘accidental’ cell death or necrosis
that results in cellular swelling, loss
of membrane integrity, and
inflammation, apoptosis is
characterized by the methodical
disassembly of the cell indicated by
cytoplasmic shrinkage and
membrane blebbing. The wave of
death progresses from the cytoplasm
to the nucleus, leading to chromatin
condensation and DNA
fragmentation. The last step of
apoptosis is the breakdown of the
cell into apoptotic bodies that are
consequently engulfed by
surrounding cells, quietly eliminating
the cell.
Executioners and inhibitors of
apoptosis
Although the stimuli leading to
programmed cell death are extremely
diverse, they lead to a common
effector pathway. The core
components of cellular suicide were
originally discovered using
Caenorhabditis elegans as a model
system. Genetic studies identified
two genes that are essential for the
promotion of apoptosis, ced-3 and
ced-4, and one gene that is essential
for the inhibition of apoptosis, ced-9.
A slide show of apoptosis in C. elegans
can be found at http://www.
ed.ac.uk/%7Emig/apopt/migapo.html.
Counterparts of these genes have
been discovered in higher organisms
and they constitute gene families
important for cell death. CED-3
homologs form the caspase family,
CED-4 is represented by Apaf-1 and
CED-9 homologs form the Bcl-2
family. Comprehensive lists of
proteins involved in apoptosis can be
found in the Apoptosis Glossary
(http://www.biosource.com/content/
apop/glossary.html) and in an
alphabetical index of apoptosis
proteins (http://www-personal.umich.
edu/~ino/List/alphabet.html).
Caspases
To date, 14 mammalian homologs
of CED-3 make up a family of
aspartate-specific cysteine proteases
termed caspases. Caspases are
synthesized as zymogens, which
have low intrinsic enzymatic activity.
After receiving a death stimulus, the
caspases are proteolytically processed
to their fully active heterotetrameric
forms composed of two identical
subunits of ~20 kDa plus two
identical subunits of ~10 kDa. The
crystal structure of active caspase 1
and 3 can be seen at the ICE family
of cysteine proteases web page
(http://www.enzim.hu/~gaspar/caspase/
index.htm) and the Caspase website
(http://pps97.cryst.bbk.ac.uk/
assignments/projects/criekinge/). Active
caspases ignite a proteolytic cascade
that leads to the cleavage of cellular
substrates necessary for normal
structural integrity and survival.
Knockout studies of many caspases
have revealed their absolute
importance in normal development
(see BioMedNet’s Mouse Knockout
and Mutation Database at http://www.
biomednet.com/db/mkmd). The
Caspases website (see above)
includes a list of useful references
and the alphabetical index of
apoptotic proteins also contains a list
of recent reviews.
Apaf-1
The mammalian homolog of
CED-4 is Apaf-1, a molecule
required for activation of caspase-9.
Apaf-1 can directly interact with
caspase-9, as well as with the
inhibitors of cell death, Bcl-2 and
Bcl-xL. These core components
seem to play a role by integrating a
non-receptor mediated death
stimulus. Apaf-1 deficiency leads to
embryonic death caused by severe
neuronal hyperplasia. For knockouts
pertaining to apoptosis see the Mouse
Knockout and Mutation Database.
Bcl-2 family
The mammalian Bcl-2 family of
proteins consists of both activators
and inhibitors of cell death. One of
the inhibitors, Bcl-2, is most closely
related to the C. elegans anti-apoptotic
protein CED-9. The pro-apoptotic
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Bcl-2 relatives also have a C. elegans
homolog, termed EGL-1. The pro-
apoptotic members act by binding
and inhibiting the anti-apoptotic
Bcl-2 family members. Inactivation
of the prosurvival genes bcl-2 or bcl-
xL leads to inappropriate cell suicide.
The Bcl-2 family and links to
important papers and reviews can be
found at the alphabetical index
mentioned above. 
Death receptors
One important component of
mammalian apoptosis that appears to
have evolved in higher organisms is
the family of tumor necrosis factor
(TNF) receptors. A subset of this
family, known as death receptors, act
to receive external cues for cell
death. Upon engagement of the cell-
surface receptor by a cognate death
ligand, the receptor can transmit its
signal to the intracellular effector
machinery of apoptosis via adaptor
proteins. This is especially important
in homeostasis of the immune
system. The growing family of TNF
receptors and their cognate ligands
can be seen at the New TNF
Nomenclature web page (http://www.
hugo-international.org/users/hester/
tnftop.html), the Apoptosis Special
Interest Site (http://biochem.
boehringer-mannheim.com/techserv/
apoptosis/) and the alphabetical index
referenced earlier. 
Adaptor molecules
The adaptor proteins link the
death receptors or other apoptosis
regulators to the caspases. In general,
these molecules have at least two
motifs that characterize them as
adaptor molecules. The motifs can
be a death domain (DD), a death
effector domain (DED) or a caspase
activation and recruitment domain
(CARD). The Fas death receptor is
the prototypic example of a protein
that utilizes adaptor molecules to
transmit the death signal. After Fas
ligand binding, the DD-containing
Fas receptor recruits the
DD-containing adaptor molecule
FADD via a DD homotypic
interaction. FADD also contains a
DED, which in turn recruits caspase-
8 via the enzyme’s own DED
regions. Caspase-8 aggregation leads
to its activation, thus initiating the
proteolytic caspase cascade that
results in cell death. Numerous other
adaptor molecules grouped by their
functional domains can be seen at
the Death Domain site
(http://www.isrec.isb-sib.ch/domains/
dd/) and the alphabetical index
described above.
Other inhibitors
To keep the activation of
apoptosis in check, there are many
inhibitors acting at all levels of the
death pathway. In general, inhibitors
of the death pathway act either to
prevent molecules from binding to
their activator or by forming a
complex with an active protease to
render it inactive. Viruses have also
exploited inhibitors of cell death to
promote their own replication. A list
of cell death inhibitors can be found
at http://www-personal.umich.edu/~ino/
List/alphabet.html under Bcl-2,
BIR-containing proteins and viral
inhibitors.
Apoptosis community
The field of apoptosis is growing
at a fervent pace, as are is the
number of people who need to keep
up with the current news, discussions
and meetings. To tap into the
community and its activities, go to
the Cell Death Society’s home page
(http://www.celldeath-apoptosis.org/) or
Apoptosis Online (http://www.
apopnet.com/). 
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